Bert Geer, DO
Obstetrics & Gynecology · Cookeville, TNNPI 1922099449
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (58.1%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Coloplast accounts for 86.3% of it on its own, with 32 other manufacturers making up the rest. Reporting peaked in 2019 at $25,153 and has fallen 78.1% since, to $5,507 in 2025. Among obstetrics & gynecology clinicians in TN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 375 payments — averaging $222.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$72K
- Intuitive Surgical$6K
- Astellas Pharma US Inc$1K
- AbbVie$676
- Medtronic$610
- Sumitomo Pharma America, Inc.$395
- plus $3K from 27 others
What the payments were for
- Consulting fees$18,05022%
- Speaking & faculty fees$3500%
- Travel & lodging$6,5648%
- Food & beverage$9,90912%
- Education$48,41958%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 126 | $71,867 |
| Intuitive Surgical | 35 | $6,201 |
| Astellas Pharma US Inc | 43 | $1,026 |
| AbbVie(2 entities) | 37 | $676 |
| Medtronic(2 entities) | 15 | $610 |
| Sumitomo Pharma America, Inc. | 22 | $395 |
| Richard Wolf Medical Instruments Corp. | 2 | $377 |
| Pfizer | 28 | $375 |
| Axonics, Inc. | 5 | $327 |
| Conmed Corporation | 1 | $171 |
| Stryker | 1 | $165 |
| Urovant Sciences Inc | 8 | $139 |
| Boston Scientific | 5 | $139 |
| Therapeuticsmd, Inc. | 9 | $120 |
| Applied Medical Resources Corporation | 2 | $112 |
| Coopersurgical, Inc. | 3 | $65 |
| Laborie Medical Technologies Corp. | 4 | $61 |
| Exeltis, USA Inc. | 3 | $50 |
| Olympus America Inc. | 3 | $45 |
| Duchesnay USA Incorporated | 3 | $44 |
| Covidien LP | 2 | $43 |
| Mayne Pharma Commercial LLC | 3 | $42 |
| Myovant Sciences Inc. | 2 | $39 |
| Alpha Orthopedic Systems | 2 | $32 |
| Kowa Pharmaceuticals America, Inc. | 2 | $31 |
| Amgen | 2 | $30 |
| Baxter Healthcare | 1 | $23 |
| Caldera Medical, Inc | 1 | $18 |
| Bayer | 1 | $17 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Organon | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
| Mylan Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$66,520
- Da Vinci Surgical System$5,071
- AXIS$357
- FEMALE INCONTINENCE$324
- Bulkamid$238
- AIRSEAL$171
- VCARE$171
- CONMED SPECIMEN RETRIEVAL$171
- VISICLEAR$171
- CONMED HANDHELD INSTRUMENTS$171
- 1788$165
- INTERSTIM$151
- SUPRIS$102
- Axonics$101
How this compares
$83,291 in reported general payments places this provider in the 95th percentile of 763 obstetrics & gynecology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 126 | $82,147 |
| GemtesaVibegron | 71 | $44,353 |
| Estradiol | 342 | $22,134 |
| Solifenacin Succinate | 254 | $20,555 |
| ElmironPentosan Polysulfate Sodium | 12 | $15,189 |
| PremarinEstrogens, Conjugated | 15 | $6,586 |
| Trospium Chloride | 30 | $1,964 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 171 | $1,832 |
| NitrofurantoinNitrofurantoin Macrocrystal | 36 | $904 |
| Methenamine Hippurate | 11 | $744 |
| Oxybutynin Chloride | 13 | $365 |
| Cephalexin | 22 | $221 |
| Dicyclomine Hcl | 12 | $192 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 60 | $175 |
| Imipramine Hcl | 18 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $1,026 | $82,147126 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $395 | $44,35371 claims |
| PfizerPremarin | $375 | $6,58615 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 763 obstetrics & gynecology providers in Tennessee.
Other obstetrics & gynecology in Cookeville
- Grover MayJohnson City$916K
- John GreenElizabethton$878K
- Brent LaingElizabethton$480K
- Larry FieldsKnoxville$323K
- Michael SwanNashville$146K
- Clarinda Burton-ShannonLebanon$114K
- Royce AdkinsNashville$95K
- Olga MuldoonNashville$91K
- Kimberly LooneyNashville$84K
- Benjamin ChappellMemphis$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.